Therapeutics: Interleukin-1 receptor-associated kinase 1 (IRAK1)

Patient sample, cell culture and mouse studies suggest inhibiting IRAK1 could help treat triple-negative breast cancer (TNBC). IRAK1 levels were higher in tumor samples from patients with aggressive T...